GLENMARK PHARMACEUTICALS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,053 INR | -0.68% |
|
+1.82% | +23.34% |
| Apr. 29 | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines | MT |
| Apr. 25 | Glenmark Lifesciences' Net Profit Slides in Fiscal Q4 | MT |
Quotes 5-day view
Delayed Quote NSE India S.E.| 2024-04-26 | 2024-04-29 | 2024-04-30 | 2024-05-02 | 2024-05-03 | |
|---|---|---|---|---|---|
| Last | 1079.35 ₹ | 1071.1 ₹ | 1057.2 ₹ | 1060.5 ₹ | 1,053 ₹ |
| Volume | 475 440 | 442 802 | 952 244 | 324 107 | 845 266 |
| Change | -0.09% | -0.76% | -1.30% | +0.31% | -0.68% |
| Opening | 1,085.00 | 1,090.00 | 1,075.00 | 1,060.35 | 1,062 |
| High | 1,088.75 | 1,098.00 | 1,081.60 | 1,068.95 | 1,071 |
| Low | 1,061.25 | 1,063.05 | 1,054.50 | 1,053.65 | 1,045 |
Performance
| 1 day | -0.68% | ||
| 1 week | +1.82% | ||
| Current month | +9.90% | ||
| 1 month | +7.21% | ||
| 3 months | +17.59% | ||
| 6 months | +40.41% | ||
| Current year | +23.34% | ||
| 1 year | +93.66% | ||
| 3 years | +82.61% | ||
| 5 years | +64.99% | ||
| 10 years | +74.23% |
Volumes
marketsDaily volume
845 266
Estimated daily volume
1 066 684
Avg. Volume 20 sessions
717 886
Daily volume ratio
1.49
Avg. Volume 20 sessions INR
756 149 323.80
Avg. Volume 20 sessions USD
9 063 205.80
Record volume 1
89 266 590
Record volume 2
65 123 680
Record volume 3
39 631 540
Capital turnover ratio
0.00
Float rotation
0.01
Basic data
Capitalization (INR)
299 161 103 537
Capitalization (USD)
3 585 744 987
Net sales (INR)
129 901 100 000
Net sales (USD)
1 556 994 585
Number of employees
15 556
Sales / Employee (INR)
8 350 546
Sales / Employee (USD)
100 090
Free-Float
49.03 %
Free-Float capitalization (INR)
146 690 608 424
Free-Float capitalization (USD)
1 758 233 633
Average Daily Capital Traded
0.25%
Highs and lows
1 week
1 033.30
1 098.00
1 month
959.051 098.00
Current year
771.001 098.00
1 year
536.251 098.00
3 years
348.501 098.00
5 years
161.651 098.00
10 years
161.651 262.90
Indicators
Moving average 5 days
1 069.69
Moving average 20 days
1 038.65
Moving average 50 days
964.14
Moving average 100 days
912.39
Price spread / (MMA5)
+1.56%
Price spread / (MMA20)
-1.39%
Price spread / (MMA50)
-8.46%
Price spread / (MMA100)
-13.38%
STIM
RSI 9 days
58.08
RSI 14 days
61.42
Sector Comparison - Generic Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.68% | +1.82% | +23.34% | +93.66% | 3.59B | ||
| -0.52% | +1.78% | +19.98% | +55.30% | 43.67B | ||
| -2.73% | +0.66% | +20.67% | +36.86% | 22.51B | ||
| +1.80% | +1.50% | +14.75% | - | 14.6B | ||
| +0.33% | +5.80% | +14.32% | +55.25% | 13.74B | ||
| +0.95% | +3.96% | +44.72% | +92.94% | 11.91B | ||
| -0.80% | +0.65% | -8.37% | -16.25% | 7.04B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| -.--% | -1.95% | - | - | 5.73B | ||
| +0.52% | +3.48% | +10.21% | +22.69% | 5.42B | ||
| +0.31% | +10.83% | -2.27% | -11.16% | 4.81B | ||
| +1.20% | +7.63% | +6.40% | +13.95% | 4.66B | ||
| -.--% | +0.80% | +14.55% | +12.50% | 4.16B | ||
| +2.12% | -2.36% | +30.33% | +158.72% | 3.69B | ||
| -0.63% | +0.96% | -10.21% | -0.05% | 2.96B | ||
| +4.23% | +4.91% | +4.23% | +23.66% | 2.9B | ||
| Average | +0.38% | +1.68% | +13.05% | +41.39% | ||
| Weighted average by Cap. | -0.13% | +1.24% | +17.41% | +47.10% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
7ab771566c44a2a50fddc24436f26.3LT0JlW2Grp35G6pQ_Hh8Jb0TBiYyZRwkigAuXbcGCk.8dycczv9bo0gvVaeKYDTw-y4J3Xzp60b2ExM5jjqV3yZ4pNwY4VZgyKtGQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 06:15:55 am | 1,053 | 15 | 845,266 |
| 06:12:19 am | 1,053 | 10 | 845,251 |
| 06:00:03 am | 1,050 | 43 | 845,241 |
| 05:59:58 am | 1,050 | 252 | 845,198 |
| 05:59:52 am | 1,053 | 177 | 844,946 |
| 05:59:45 am | 1,050 | 106 | 844,769 |
| 05:59:39 am | 1,053 | 138 | 844,663 |
| 05:59:33 am | 1,053 | 2,129 | 844,525 |
| 05:59:27 am | 1,050 | 560 | 842,396 |
Monthly variations
Annual change
| 2024 | +24.19% | ||
| 2023 | +101.33% | ||
| 2022 | -19.75% | ||
| 2021 | +7.10% | ||
| 2020 | +42.03% | ||
| 2019 | -49.87% | ||
| 2018 | +16.53% | ||
| 2017 | -33.06% | ||
| 2016 | -3.63% | ||
| 2015 | +19.70% | ||
| 2014 | +44.27% | ||
| 2013 | +1.00% | ||
| 2012 | +80.05% | ||
| 2011 | -18.93% | ||
| 2010 | +31.27% | ||
| 2009 | -6.84% | ||
| 2008 | -50.32% | ||
| 2007 | +97.78% | ||
| 2006 | +92.22% | ||
| 2005 | +29.33% | ||
| 2004 | +238.85% | ||
| 2003 | +198.25% | ||
| 2002 | +26.86% | ||
| 2001 | -7.37% | ||
| 2000 | -62.36% |
- Stock Market
- Equities
- GLENMARK Stock
- Quotes Glenmark Pharmaceuticals Limited
